BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS Journal

publication venue for

Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a] pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition. 43. 2021
Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators. 41. 2021
P-2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffold. 15:2771-2775. 2005
Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1N-benzylamides. 13:1353-1357. 2003
C6 modification of the pyridinone core of thrombin inhibitor L-374,087 as a means of enhancing its oral absorption. 8:1719-1724. 1998
L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor. 8:817-822. 1998

International Standard Serial Number (ISSN)

0960-894X

Electronic International Standard Serial Number (EISSN)

1464-3405

journal abbreviation

BIOORG MED CHEM LETT